125 related articles for article (PubMed ID: 18184514)
1. Inflammation from sterile dialysis solutions and the longevity of the peritoneal barrier.
Flessner MF
Clin Nephrol; 2007 Dec; 68(6):341-8. PubMed ID: 18184514
[TBL] [Abstract][Full Text] [Related]
2. Sterile solutions and peritoneal inflammation.
Flessner MF
Contrib Nephrol; 2006; 150():156-165. PubMed ID: 16721006
[TBL] [Abstract][Full Text] [Related]
3. Mediators of inflammation and fibrosis.
Lai KN; Tang SC; Leung JC
Perit Dial Int; 2007 Jun; 27 Suppl 2():S65-71. PubMed ID: 17556333
[TBL] [Abstract][Full Text] [Related]
4. Inflammation in peritoneal dialysis.
Lai KN; Leung JC
Nephron Clin Pract; 2010; 116(1):c11-8. PubMed ID: 20460934
[TBL] [Abstract][Full Text] [Related]
5. Factors increasing severity of peritonitis in long-term peritoneal dialysis patients.
Park MS
Adv Ren Replace Ther; 1998 Jul; 5(3):185-93. PubMed ID: 9686629
[TBL] [Abstract][Full Text] [Related]
6. Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis.
Schaefer B; Bartosova M; Macher-Goeppinger S; Sallay P; Vörös P; Ranchin B; Vondrak K; Ariceta G; Zaloszyc A; Bayazit AK; Querfeld U; Cerkauskiene R; Testa S; Taylan C; VandeWalle J; Yap Y; Krmar RT; Büscher R; Mühlig AK; Drozdz D; Caliskan S; Lasitschka F; Fathallah-Shaykh S; Verrina E; Klaus G; Arbeiter K; Bhayadia R; Melk A; Romero P; Warady BA; Schaefer F; Ujszaszi A; Schmitt CP
Kidney Int; 2018 Aug; 94(2):419-429. PubMed ID: 29776755
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
[TBL] [Abstract][Full Text] [Related]
8. [Icodextrine peritoneal dialysis solution in clinical practice].
Opatrná S
Vnitr Lek; 2008 Dec; 54(12):1155-60. PubMed ID: 19140524
[TBL] [Abstract][Full Text] [Related]
9. Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients.
Aguilera A; Yáñez-Mo M; Selgas R; Sánchez-Madrid F; López-Cabrera M
Curr Opin Investig Drugs; 2005 Mar; 6(3):262-8. PubMed ID: 15816502
[TBL] [Abstract][Full Text] [Related]
10. The effect of fibrosis on peritoneal transport.
Flessner MF
Contrib Nephrol; 2006; 150():174-180. PubMed ID: 16721008
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells-Peritoneal Stroma Interactions.
Terri M; Trionfetti F; Montaldo C; Cordani M; Tripodi M; Lopez-Cabrera M; Strippoli R
Front Immunol; 2021; 12():607204. PubMed ID: 33854496
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-to-mesenchymal transition of the mesothelial cell--its role in the response of the peritoneum to dialysis.
Selgas R; Bajo A; Jiménez-Heffernan JA; Sánchez-Tomero JA; Del Peso G; Aguilera A; López-Cabrera M
Nephrol Dial Transplant; 2006 Jul; 21 Suppl 2():ii2-7. PubMed ID: 16825254
[TBL] [Abstract][Full Text] [Related]
13. Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms.
Bazargani F
Swed Dent J Suppl; 2005; (171):1-57, i. PubMed ID: 15847249
[TBL] [Abstract][Full Text] [Related]
14. Recent concepts in the molecular biology of the peritoneal membrane - implications for more biocompatible dialysis solutions.
Mortier S; De Vriese AS; Lameire N
Blood Purif; 2003; 21(1):14-23. PubMed ID: 12566656
[TBL] [Abstract][Full Text] [Related]
15. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions.
Aroeira LS; Aguilera A; Sánchez-Tomero JA; Bajo MA; del Peso G; Jiménez-Heffernan JA; Selgas R; López-Cabrera M
J Am Soc Nephrol; 2007 Jul; 18(7):2004-13. PubMed ID: 17568021
[TBL] [Abstract][Full Text] [Related]
16. Morphological and functional changes in the dialysed peritoneal cavity: impact of more biocompatible solutions.
Devuyst O; Topley N; Williams JD
Nephrol Dial Transplant; 2002; 17 Suppl 3():12-5. PubMed ID: 11912293
[TBL] [Abstract][Full Text] [Related]
17. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
[TBL] [Abstract][Full Text] [Related]
18. [Selected indices of peritoneal fibrosis in patients undergoing peritoneal dialysis].
Penar J; Weyde W; Krajewska M; Madziarska K; Gołebiowski T; Szymczak M; Kłak R; Klinger M
Postepy Hig Med Dosw (Online); 2009 Apr; 63():200-4. PubMed ID: 19502680
[TBL] [Abstract][Full Text] [Related]
19. [Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis].
Haag-Weber M
Wien Klin Wochenschr; 2005; 117 Suppl 6():89-97. PubMed ID: 16437339
[TBL] [Abstract][Full Text] [Related]
20. [Effect of glucose peritoneal dialysates on the transmesothelial electrical resistance and cellular migration of monolayer human peritoneal mesothelial cell].
Ling G; Zhu X; Xia Y; Liu F; Peng Y; Duan S; Liu H; Liu Y; Sun L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 May; 34(5):418-24. PubMed ID: 19483290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
